scholarly article | Q13442814 |
P356 | DOI | 10.1111/J.1600-0897.2010.00913.X |
P698 | PubMed publication ID | 20825381 |
P2093 | author name string | Alice Gilman-Sachs | |
Hyunkyong Ahn | |||
Joanne Kwak-Kim | |||
Jooncheol Park | |||
P2860 | cites work | A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase | Q24324172 |
Prevention of allogeneic fetal rejection by tryptophan catabolism | Q24336018 | ||
Human decidual NK cells form immature activating synapses and are not cytotoxic | Q24535370 | ||
Angiopoietin-1 and angiopoietin-2 activate trophoblast Tie-2 to promote growth and migration during placental development | Q24669641 | ||
Inhibition of T cell proliferation by macrophage tryptophan catabolism | Q28142922 | ||
Thrombophilia and pregnancy complications: cause or association? | Q28218550 | ||
Hofbauer cells in early human placenta: possible implications in vasculogenesis and angiogenesis | Q28292287 | ||
Toll-like receptors in innate immunity | Q28297257 | ||
Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation | Q28344659 | ||
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours | Q29618396 | ||
IL-4 and IL-13 regulate the induction of indoleamine 2,3-dioxygenase activity and the control of Toxoplasma gondii replication in human fibroblasts activated with IFN-gamma | Q31946843 | ||
Preeclamptic women are deficient of interleukin-10 as assessed by cytokine release of trophoblast cells in vitro | Q33188491 | ||
Characterization of macrophages in the decidual atherotic spiral artery with special reference to the cytology of foam cells | Q33225260 | ||
Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus | Q33458388 | ||
The immunology of preeclampsia | Q33548004 | ||
International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop | Q33685960 | ||
Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence | Q33727775 | ||
Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation? | Q33740214 | ||
Oxidative stress in the pathogenesis of preeclampsia | Q33796834 | ||
Invasive cytotrophoblast apoptosis in pre-eclampsia | Q33848112 | ||
AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase | Q44385661 | ||
Indoleamine 2,3-dioxygenase (IDO) expression in invasive extravillous trophoblast supports role of the enzyme for materno-fetal tolerance | Q44829417 | ||
Association of C677T polymorphism in the methylenetetrahydrofolate reductase gene with hypertension in pregnancy and pre-eclampsia: a meta-analysis | Q45018274 | ||
Antibodies from preeclamptic patients stimulate increased intracellular Ca2+ mobilization through angiotensin receptor activation | Q45069619 | ||
Anti-beta 2 glycoprotein I antibodies in a general obstetric population: preliminary results on the prevalence and correlation with pregnancy outcome. Anti-beta2 glycoprotein I antibodies are associated with some obstetrical complications, mainly pr | Q45101265 | ||
TNF alpha concentrations and mRNA expression are increased in preeclamptic placentas | Q45102738 | ||
Inherited thrombophilia and preeclampsia within a multicenter cohort: the Montreal Preeclampsia Study | Q46205655 | ||
Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human mesangial cells and induce interleukin-6 and plasminogen activator inhibitor-1 secretion | Q46344658 | ||
The G20210A prothrombin-gene mutation and the plasminogen activator inhibitor (PAI-1) 5G/5G genotype are associated with early onset of severe preeclampsia | Q46447105 | ||
Mechanism of the induction of angiogenesis by human neoplastic lymphoid tissue: Studies employing bovine aortic endothelial cellsin vitro | Q46662812 | ||
Anticardiolipin and anti-beta2-glycoprotein-I antibodies in preeclampsia | Q47704924 | ||
Association of Leiden mutation in factor V gene with hypertension in pregnancy and pre-eclampsia: a meta-analysis | Q47816789 | ||
Toll-like receptor-2 expression in normal and pathologic human placenta. | Q47855080 | ||
Increased frequency of genetic thrombophilia in women with complications of pregnancy | Q47868847 | ||
Tissue distribution of indoleamine 2,3-dioxygenase in normal and malaria-infected tissue | Q47869902 | ||
Serum granulysin is a marker for Th1 type immunity in pre-eclampsia | Q47927216 | ||
Neonates born to pre-eclamptic mothers have a higher percentage of natural killer cells (CD3-/CD56+16+) in umbilical cord blood than those without pre-eclampsia. | Q48031808 | ||
Association of maternal killer-cell immunoglobulin-like receptors and parental HLA-C genotypes with recurrent miscarriage. | Q48540664 | ||
How Does the maternal immune system contribute to the development of pre-eclampsia? | Q48545136 | ||
Cytotoxicity of tumour necrosis factor-alpha and gamma-interferon against primary human placental trophoblasts. | Q50767140 | ||
Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. | Q51583985 | ||
Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis? | Q51589418 | ||
Activated T lymphocytes in pre-eclampsia. | Q51974454 | ||
Regulation of C-C motif chemokine ligand 2 and its receptor in human decidual stromal cells by pregnancy-associated hormones in early gestation. | Q51977836 | ||
The etiological role of allogeneic fetal rejection in pre-eclampsia. | Q51983335 | ||
Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. | Q52010655 | ||
Aberrant positioning of trophoblast and lymphocytes in the feto-maternal interface with pre-eclampsia. | Q52178148 | ||
Expression of interleukin-10 in human gestational tissues. | Q52192177 | ||
First trimester trophoblast cells secrete Fas ligand which induces immune cell apoptosis. | Q52552707 | ||
Agonistic autoantibodies to the AT1 receptor in a transgenic rat model of preeclampsia. | Q52940276 | ||
Maternal cytokine production patterns in women with pre-eclampsia. | Q52978651 | ||
Expression of the placental cytokines tumor necrosis factor alpha, interleukin 1beta, and interleukin 10 is increased in preeclampsia. | Q53680742 | ||
High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia. | Q54096102 | ||
BACTERIURIA IN PREGNANCY. | Q54116774 | ||
Resistance of malignant trophoblast cells to both the anti-proliferative and anti-invasive effects of transforming growth factor-beta. | Q54195428 | ||
Toll-like receptor 4: a potential link between "danger signals," the innate immune system, and preeclampsia? | Q54644102 | ||
Macrophages in human reproductive tissues contain luteinizing hormone/chorionic gonadotropin receptors. | Q54771576 | ||
Placental stress and pre-eclampsia: a revised view. | Q54774592 | ||
Placental deficiency of interleukin-10 (IL-10) in preeclampsia and its relationship to an IL10 promoter polymorphism | Q57500426 | ||
Expression and regulation of the pattern recognition receptors Toll-like receptor-2 and Toll-like receptor-4 in the human placenta | Q57969580 | ||
Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor | Q33848380 | ||
Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts | Q33893072 | ||
Leucocyte populations and cytokine regulation in human uteroplacental tissues | Q33921322 | ||
Corpse clearance defines the meaning of cell death | Q33922730 | ||
Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies | Q33930498 | ||
Pathogenesis and genetics of pre-eclampsia | Q33934445 | ||
Cytokine network at the feto-maternal interface | Q33989721 | ||
Placental debris, oxidative stress and pre-eclampsia | Q34032003 | ||
Decreased tryptophan catabolism by placental indoleamine 2,3-dioxygenase in preeclampsia | Q34183393 | ||
Uterine natural killer cells: insights into their cellular and molecular biology from mouse modelling | Q34258287 | ||
The factor V Leiden mutation may predispose women to severe preeclampsia. | Q34404132 | ||
Localisation of indoleamine 2,3-dioxygenase and kynurenine hydroxylase in the human placenta and decidua: implications for role of the kynurenine pathway in pregnancy. | Q34425660 | ||
Intrauterine infection and prematurity | Q34580869 | ||
Characteristics of the fetal/maternal interface with potential usefulness in the development of future immunological and pharmacological strategies | Q34605762 | ||
Viral infection of the trophoblast: time to take a serious look at its role in abnormal implantation and placentation? | Q34683539 | ||
Pathophysiology of preeclampsia: linking placental ischemia/hypoxia with microvascular dysfunction. | Q34702420 | ||
Natural killer cells and pregnancy | Q34810250 | ||
Role of the Fas/Fas ligand system in female reproductive organs: survival and apoptosis | Q34977059 | ||
Adeno-associated virus-2 (AAV-2) causes trophoblast dysfunction, and placental AAV-2 infection is associated with preeclampsia | Q35088398 | ||
Antiphospholipid syndrome: obstetric diagnosis, management, and controversies | Q35150503 | ||
Th1/Th2 balance in preeclampsia | Q35190885 | ||
Human uterine leukocytes and pregnancy | Q35598741 | ||
Cytokine secretion by decidual lymphocytes in transient hypertension of pregnancy and pre-eclampsia | Q35609435 | ||
Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling | Q35681804 | ||
Differences in apoptotic susceptibility of cytotrophoblasts and syncytiotrophoblasts in normal pregnancy to those complicated with preeclampsia and intrauterine growth restriction | Q35749051 | ||
Preeclampsia is associated with widespread apoptosis of placental cytotrophoblasts within the uterine wall | Q35787199 | ||
Mapping the theories of preeclampsia: the role of homocysteine | Q36026224 | ||
Autoantibody-mediated angiotensin receptor activation contributes to preeclampsia through tumor necrosis factor-alpha signaling | Q36050771 | ||
Cell type-specific expression and function of toll-like receptors 2 and 4 in human placenta: implications in fetal infection | Q36119940 | ||
The role of apoptosis in the regulation of trophoblast survival and differentiation during pregnancy | Q36131659 | ||
Angiogenic factors and natural killer (NK) cells in the pathogenesis of preeclampsia | Q36287399 | ||
Interaction of glucocorticoids with macrophages. Identification of glucocorticoid receptors in monocytes and macrophages | Q36340383 | ||
Biochemical actions of glucocorticoids on macrophages in culture. Specific inhibition of elastase, collagenase, and plasminogen activator secretion and effects on other metabolic functions | Q36340441 | ||
Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites | Q36376598 | ||
Agonistic antibodies directed at the angiotensin II, AT1 receptor in preeclampsia | Q36380482 | ||
Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success | Q36399286 | ||
Hormonal regulation of uterine macrophages | Q36511316 | ||
Immunoregulation in normal pregnancy and pre-eclampsia: an overview | Q36684096 | ||
The role of the immune system in preeclampsia | Q36791219 | ||
NK cells and pre-eclampsia | Q36812227 | ||
Association between maternal infections and preeclampsia: a systematic review of epidemiologic studies | Q36852798 | ||
AT1-receptor autoantibodies and uteroplacental RAS in pregnancy and pre-eclampsia | Q37132801 | ||
Clinical implication of natural killer cells and reproduction | Q37135758 | ||
Are we getting closer to a Nobel prize for unraveling preeclampsia? | Q37307973 | ||
Inflammation and pregnancy. | Q37390203 | ||
The roles of TLRs, RLRs and NLRs in pathogen recognition | Q37402176 | ||
Toll-like receptors and pregnancy: trophoblast as modulators of the immune response | Q37428072 | ||
Specific subsets of immune cells in human decidua differ between normal pregnancy and preeclampsia--a prospective observational study | Q37460699 | ||
The pathophysiology of pre-eclampsia: current clinical concepts | Q37598132 | ||
Cytokine networks in the uteroplacental unit: macrophages as pivotal regulatory cells | Q38741739 | ||
LPS induces secretion of chemokines by human syncytiotrophoblast cells in a MAPK-dependent manner | Q39192838 | ||
Studies on activity of NK cells in preeclampsia patients. | Q40473246 | ||
Divergent trophoblast responses to bacterial products mediated by TLRs | Q40512735 | ||
B7 family molecules are favorably positioned at the human maternal-fetal interface | Q40668007 | ||
Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division | Q40686234 | ||
The in-vitro characterization of induced apoptosis in placental cytotrophoblasts and syncytiotrophoblasts | Q40767122 | ||
Preeclampsia: an excessive maternal inflammatory response to pregnancy | Q40824430 | ||
Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? | Q40841827 | ||
Elevated IL-6 in midtrimester amniotic fluid is involved with the onset of preeclampsia | Q40857999 | ||
Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism | Q40899870 | ||
Trophoblastic cell lines generated from tumour necrosis factor receptor-deficient mice reveal specific functions for the two tumour necrosis factor receptors | Q40962173 | ||
Sex steroid hormones and macrophage function | Q41018203 | ||
Heterogeneous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications | Q41243028 | ||
Placental cytokines and the pathogenesis of preeclampsia | Q41452017 | ||
Human indolylamine 2,3-dioxygenase. Its tissue distribution, and characterization of the placental enzyme | Q42129941 | ||
Expression and subcellular localization of TLR-4 in term and first trimester human placenta. | Q42487647 | ||
Progress toward identifying potential markers for preeclampsia: role of agonistic autoantibody to the angiotensin II type I receptor | Q42701351 | ||
The role of invariant NKT cells in pre-eclampsia | Q43413754 | ||
Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. | Q43514619 | ||
Human primary CD4 + T cells activated in the presence of IFN-alpha 2b express functional indoleamine 2,3-dioxygenase | Q43664348 | ||
Macrophage-induced apoptosis limits endovascular trophoblast invasion in the uterine wall of preeclamptic women | Q43705726 | ||
Anti-vascular endothelial cell antibodies in severe preeclampsia | Q43864226 | ||
Treatment of periodontal disease and the risk of preterm birth | Q43886645 | ||
Localization of indoleamine 2,3-dioxygenase and 4-hydroxynonenal in normal and pre-eclamptic placentae | Q44025506 | ||
Hypoxia-reoxygenation: a potent inducer of apoptotic changes in the human placenta and possible etiological factor in preeclampsia. | Q44044678 | ||
Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human trophoblast cells | Q44320558 | ||
Phenotypic characterization of human decidual macrophages | Q44328156 | ||
P433 | issue | 4 | |
P921 | main subject | maternal health | Q6786626 |
pre-eclampsia | Q61335 | ||
P304 | page(s) | 377-394 | |
P577 | publication date | 2010-09-06 | |
P1433 | published in | American Journal of Reproductive Immunology | Q15761228 |
P1476 | title | Immunologic characteristics of preeclampsia, a comprehensive review | |
P478 | volume | 65 |
Q28069689 | A Dormant Microbial Component in the Development of Preeclampsia |
Q38649632 | A meta-analysis of neonatal health outcomes from oocyte donation. |
Q64067049 | Altered Tryptophan Catabolism in Placentas From Women With Pre-eclampsia |
Q36480556 | Ambient Fine Particulate Matter, Nitrogen Dioxide, and Hypertensive Disorders of Pregnancy in New York City |
Q36096862 | Apoptosis signaling is altered in CD4⁺CD25⁺FoxP3⁺ T regulatory lymphocytes in pre-eclampsia. |
Q38124028 | Cell death mechanisms and potentially cytotoxic natural immune cells in human pregnancies complicated by preeclampsia |
Q37454681 | Cohort profile: the Finnish Genetics of Pre-eclampsia Consortium (FINNPEC). |
Q35587280 | Complement factor B activation in patients with preeclampsia. |
Q26830707 | Cytokines as key players in the pathophysiology of preeclampsia |
Q56996369 | Disruption in the Regulation of Immune Responses in the Placental Subtype of Preeclampsia |
Q40858713 | Effects of Lipopolysaccharide on Human First Trimester Villous Cytotrophoblast Cell Function In Vitro. |
Q37404418 | Evidence of sexual dimorphism in the placental function with severe preeclampsia. |
Q38735199 | Integration of metabolomic and transcriptomic networks in pregnant women reveals biological pathways and predictive signatures associated with preeclampsia |
Q40129829 | Lifetime Exposure to Intimate Partner Violence and Proinflammatory Cytokine Levels Across the Perinatal Period |
Q48253922 | Lnc-DC mediates the over-maturation of decidual dendritic cells and induces the increase in Th1 cells in preeclampsia. |
Q43946192 | Low dietary folate and methylenetetrahydrofolate reductase deficiency may lead to pregnancy complications through modulation of ApoAI and IFN-γ in spleen and placenta, and through reduction of methylation potential |
Q34140082 | Maternally sequestered therapeutic polypeptides - a new approach for the management of preeclampsia |
Q34359647 | Monocyte subpopulations from pre-eclamptic patients are abnormally skewed and exhibit exaggerated responses to Toll-like receptor ligands |
Q46407916 | Oxidative stress and immunological alteration in women with preeclampsia |
Q27009185 | Perinatal depression--the fourth inflammatory morbidity of pregnancy?: Theory and literature review |
Q54256280 | Placental Regulation of Inflammation and Hypoxia after TNF-α Infusion in Mice. |
Q34657074 | Plasma IL-17, IL-35, interferon-γ, SOCS3 and TGF-β levels in pregnant women with preeclampsia, and their relation with severity of disease |
Q33694254 | Polymorphisms in inflammatory genes are associated with term small for gestational age and preeclampsia |
Q58741485 | Potential role for nectin-4 in the pathogenesis of pre-eclampsia: a molecular genetic study |
Q57055935 | Pre-eclampsia: the role of highly active antiretroviral therapy and immune markers |
Q38849036 | Preeclampsia and health risks later in life: an immunological link |
Q41046727 | Preeclampsia/Eclampsia candidate genes show altered methylation in maternal leukocytes of preeclamptic women at the time of delivery |
Q46324767 | Preterm neonates show marked leukopenia and lymphopenia that are associated with increased regulatory T-cell values and diminished IL-7. |
Q36820478 | Quantification of maternal serum cell-free fetal DNA in early-onset preeclampsia |
Q38637362 | Regulatory T-cells and preeclampsia: an overview of literature |
Q47429154 | Resistance of uterine radial artery blood flow was correlated with peripheral blood NK cell fraction and improved with low molecular weight heparin therapy in women with unexplained recurrent pregnancy loss |
Q42539964 | Senescent T cells and hypertension: new ideas about old cells |
Q37565739 | Serum levels of tumor necrosis factor-α, interleukin-15 and interleukin-10 in patients with pre-eclampsia in comparison with normotensive pregnant women |
Q50326909 | The association between pre pregnancy body mass index and risk of preeclampsia: a registry based study from Tanzania. |
Q33634903 | The maternal brain: an organ with peripartal plasticity |
Q36016491 | The mucin MUC16 (CA125) binds to NK cells and monocytes from peripheral blood of women with healthy pregnancy and preeclampsia |
Q46180316 | The relationship between maternal serum prenatal screening combined with epidemiological study and early onset preeclampsia |
Q64065212 | Therapeutic Potential of Regulatory T Cells in Preeclampsia-Opportunities and Challenges |
Q64110285 | Urinary Tract Infections and Preeclampsia among Pregnant Women Attending Two Hospitals in Mwanza City, Tanzania: A 1:2 Matched Case-Control Study |
Q38502483 | Urinary proteomics analysis for renal injury in hypertensive disorders of pregnancy with iTRAQ labeling and LC-MS/MS. |
Q38124456 | Vascular dysfunction in preeclampsia |
Search more.